Delivery Order SPE2DB22D1106-SPE2DB25FEUW6
Award Date 6/24/25
Potential Completion Date 7/16/25
Potential Value $20K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $30,669.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for LENVIMA 20 mg daily dose tablets (60-count supply), with an ultimate completion date of August 29, 2025. This non-set-aside competitive award leverages AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to furnish...
- The Defense Logistics Agency awarded a $9,910.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 14 MG daily dose (60-count supply) on June 18, 2025, with completion targeted for July 11, 2025. This non-set-aside contract represents a direct pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and veteran healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,910.95 to AmerisourceBergen Drug Corp for LENVIMA 10 mg daily dose (30-count supply) on May 27, 2025, with completion scheduled for June 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's substantial Indefinite Delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a $20.4K delivery order to AmerisourceBergen Drug Corp for the supply of LENVIMA 10 mg daily dose tablets (30-count packages) under a firm fixed price contract. The award, issued on August 4, 2025, with completion targeted for August 25, 2025, represents a non-competitive delivery order executed through the company's existing indefinite delivery contract (IDC) framework. Performance will be fulfilled from AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for LENVIMA 14 mg daily dose, 60-count units. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, scheduled for completion by August 5, 2025. The award was issued on July 15, 2025, and the product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,223.24 on August 18, 2025, for the supply of LENVIMA 10 mg daily dose tablets (30-count) under a firm fixed-price contract. This non-set-aside award is funded by the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by September 9, 2025. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $10,223.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 20 MG daily dose (60-count supply) with an ultimate completion date of August 19, 2025. This non-set-aside competitive award was issued on July 29, 2025, with performance to be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. LENVIMA is a targeted cancer therapy medication, reflecting the federal government's continued reliance on...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for LENVIMA 18 mg daily dose tablets (90-count supply) valued at $10,223.24 under a firm fixed-price contract type. The award was made on August 8, 2025, with an ultimate completion date of August 29, 2025, and no set-aside designation was utilized. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical delivery. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for LENVIMA 10 MG daily dose tablets (30-count supply). This firm fixed-price, non-set-aside contract was awarded on August 18, 2025, with an ultimate completion date of September 9, 2025. LENVIMA (lenvatinib) is a targeted cancer therapy used to treat various malignancies, reflecting the pharmaceutical distributor's role in supplying specialized oncology medications to federal...
- AmerisourceBergen Drug Corp was awarded a delivery order for LENVIMA 14 mg daily dose (60-unit supply) by the Defense Logistics Agency's Medical Supply Chain on July 14, 2025, with a ceiling value of $10,223.24 and firm fixed pricing. The award is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. Performance will be completed by August...